Literature DB >> 30907057

Response to: Cardiovascular events with blood pressure lowering in patients with diabetes and systolic blood pressure below 140 mm Hg.

Shifei Wang1, Jianping Bin1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30907057      PMCID: PMC8030294          DOI: 10.1111/jch.13523

Source DB:  PubMed          Journal:  J Clin Hypertens (Greenwich)        ISSN: 1524-6175            Impact factor:   3.738


× No keyword cloud information.
  11 in total

1.  Combined angiotensin inhibition for the treatment of diabetic nephropathy.

Authors:  Linda F Fried; Nicholas Emanuele; Jane H Zhang; Mary Brophy; Todd A Conner; William Duckworth; David J Leehey; Peter A McCullough; Theresa O'Connor; Paul M Palevsky; Robert F Reilly; Stephen L Seliger; Stuart R Warren; Suzanne Watnick; Peter Peduzzi; Peter Guarino
Journal:  N Engl J Med       Date:  2013-11-09       Impact factor: 91.245

2.  Effects of blood pressure lowering on cardiovascular events, in the context of regression to the mean: a systematic review of randomized trials.

Authors:  Abdul Salam; Emily Atkins; Johan Sundström; Yoichiro Hirakawa; Dena Ettehad; Connor Emdin; Bruce Neal; Mark Woodward; John Chalmers; Eivind Berge; Salim Yusuf; Kazem Rahimi; Anthony Rodgers
Journal:  J Hypertens       Date:  2019-01       Impact factor: 4.844

3.  Efficacy, safety and tolerability of metoprolol CR/XL in patients with diabetes and chronic heart failure: experiences from MERIT-HF.

Authors:  Prakash C Deedwania; Thomas D Giles; Michael Klibaner; Jalal K Ghali; Johan Herlitz; Per Hildebrandt; John Kjekshus; Jindrich Spinar; Jiri Vitovec; Hilary Stanbrook; John Wikstrand
Journal:  Am Heart J       Date:  2005-01       Impact factor: 4.749

4.  Effect of ramipril on the incidence of diabetes.

Authors:  Jackie Bosch; Salim Yusuf; Hertzel C Gerstein; Janice Pogue; Patrick Sheridan; Gilles Dagenais; Rafael Diaz; Alvaro Avezum; Fernando Lanas; Jeffrey Probstfield; George Fodor; Rury R Holman
Journal:  N Engl J Med       Date:  2006-09-15       Impact factor: 91.245

5.  Effect of valsartan on the incidence of diabetes and cardiovascular events.

Authors:  John J McMurray; Rury R Holman; Steven M Haffner; M Angelyn Bethel; Björn Holzhauer; Tsushung A Hua; Yuri Belenkov; Mitradev Boolell; John B Buse; Brendan M Buckley; Antonio R Chacra; Fu-Tien Chiang; Bernard Charbonnel; Chun-Chung Chow; Melanie J Davies; Prakash Deedwania; Peter Diem; Daniel Einhorn; Vivian Fonseca; Gregory R Fulcher; Zbigniew Gaciong; Sonia Gaztambide; Thomas Giles; Edward Horton; Hasan Ilkova; Trond Jenssen; Steven E Kahn; Henry Krum; Markku Laakso; Lawrence A Leiter; Naomi S Levitt; Viacheslav Mareev; Felipe Martinez; Chantal Masson; Theodore Mazzone; Eduardo Meaney; Richard Nesto; Changyu Pan; Rudolf Prager; Sotirios A Raptis; Guy E H M Rutten; Herbert Sandstroem; Frank Schaper; Andre Scheen; Ole Schmitz; Isaac Sinay; Vladimir Soska; Steen Stender; Gyula Tamás; Gianni Tognoni; Jaako Tuomilehto; Alberto S Villamil; Juraj Vozár; Robert M Califf
Journal:  N Engl J Med       Date:  2010-03-14       Impact factor: 91.245

6.  Cardiorenal end points in a trial of aliskiren for type 2 diabetes.

Authors:  Hans-Henrik Parving; Barry M Brenner; John J V McMurray; Dick de Zeeuw; Steven M Haffner; Scott D Solomon; Nish Chaturvedi; Frederik Persson; Akshay S Desai; Maria Nicolaides; Alexia Richard; Zhihua Xiang; Patrick Brunel; Marc A Pfeffer
Journal:  N Engl J Med       Date:  2012-11-03       Impact factor: 91.245

7.  Cardiovascular events with blood pressure lowering in patients with diabetes and systolic blood pressure below 140 mm Hg.

Authors:  Abdul Salam; Anthony Rodgers
Journal:  J Clin Hypertens (Greenwich)       Date:  2019-03-24       Impact factor: 3.738

8.  Cardiovascular outcomes in patients with diabetes when initiating blood pressure lowering at baseline SBP between 130 and 140 mm Hg: A meta-analysis.

Authors:  Shifei Wang; Nima Moumin Djama; Yanxian Lai; Hairui Li; Wangjun Liao; Yulin Liao; Jianping Bin
Journal:  J Clin Hypertens (Greenwich)       Date:  2019-01-13       Impact factor: 3.738

Review 9.  Blood pressure lowering in type 2 diabetes: a systematic review and meta-analysis.

Authors:  Connor A Emdin; Kazem Rahimi; Bruce Neal; Thomas Callender; Vlado Perkovic; Anushka Patel
Journal:  JAMA       Date:  2015-02-10       Impact factor: 56.272

Review 10.  Effect of antihypertensive treatment at different blood pressure levels in patients with diabetes mellitus: systematic review and meta-analyses.

Authors:  Mattias Brunström; Bo Carlberg
Journal:  BMJ       Date:  2016-02-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.